About CircleDNA
CircleDNA is a company based in Hong Kong (China) founded in 2014 by Lawrence Tzang and Danny Yeung. CircleDNA has raised $15 million across 1 funding round from investors including Apis Partners and Alibaba Entrepreneurs Fund. CircleDNA offers products and services including Premium DNA Test, DNA Reports, and DNA Collection Kit. CircleDNA operates in a competitive market with competitors including AnchorDx, 23Mofang, WeGene, Universal Life and 1JKT, among others.
- Headquarter Hong Kong, China
- Founders Lawrence Tzang, Danny Yeung
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$15 M (USD)
in 1 rounds
-
Latest Funding Round
$15 M (USD), Series B
Sep 18, 2020
-
Investors
Apis Partners
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CircleDNA
CircleDNA offers a comprehensive portfolio of products and services, including Premium DNA Test, DNA Reports, and DNA Collection Kit.
Comprehensive kit for analyzing DNA to provide health and trait insights.
Detailed genetic reports on risks, nutrition, and personal traits.
Kit for easy cheek swab sample collection and submission.
People of CircleDNA
Unlock access to complete
Funding Insights of CircleDNA
CircleDNA has successfully raised a total of $15M through 1 strategic funding round. The most recent funding activity was a Series B round of $15 million completed in September 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in CircleDNA
CircleDNA has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Apis Partners and Alibaba Entrepreneurs Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and venture capital asset management firm
|
Locked | Locked | Locked | |
|
Capital and guidance are provided to startups for growth.
|
Locked | Locked | Locked |
Investor details for CircleDNA
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CircleDNA
Investment portfolio details for CircleDNA
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CircleDNA
Detailed financials for CircleDNA
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Circledna Comparisons
Peer comparison for CircleDNA
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CircleDNA
CircleDNA operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AnchorDx, 23Mofang, WeGene, Universal Life and 1JKT, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
High-throughput gene sequencing platform is developed for clinical diagnostics.
|
|
| Locked | Locked | Locked |
Provides genetic testing services to help prevent potential problems and early intervention.
|
|
| Locked | Locked | Locked |
Genetic testing is conducted using saliva for health risk detection.
|
|
| Locked | Locked | Locked |
Developer of molecular diagnostic products and gene therapy solutions
|
|
| Locked | Locked | Locked |
Online platform offering appointment booking services for genetic tests
|
Detailed competitors of CircleDNA
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Circledna
Complete news archive for CircleDNA
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CircleDNA
CircleDNA was founded in 2014 and raised its 1st funding round 6 years after it was founded.
CircleDNA is headquartered in Hong Kong, China.
Danny Yeung is the current CEO of CircleDNA. They have also founded this company.
CircleDNA is a funded company, having raised a total of $15M across 1 funding round to date.
CircleDNA was founded in 2014 in Hong Kong, China, as an internet-first diagnostics lab focused on genetic testing. Services include test kits for cardiovascular diseases, psychiatric disorders, pain management, drug responses, allergies, diabetes, and other conditions. Whole Exome Sequencing technology is utilized for detection, enabling personalized and proactive health insights through an online platform. Operations emphasize accessibility in the diagnostics sector.
CircleDNA's top competitors include AnchorDx, 23Mofang and Universal Life.
CircleDNA offers Premium DNA Test, DNA Reports, and DNA Collection Kit.
CircleDNA has 2 investors. Key investors include Apis Partners, and Alibaba Entrepreneurs Fund.